MedScout, an Austin, TX-based revenue acceleration platform for med tech commercial operations, raised $5M in Seed funding.
The round was led by Stage 2 Capital, with participation from LiveOak Venture Partners, as well as Alumni Ventures, and a16z’s Scout Fund. Mandy Cole and Mike Marcantonio, Partner at LiveOak Venture Partners, will join the MedScout Board
The company intends to use the funds to expand the adoption of its advanced sales intelligence tools purpose-built for selling into healthcare.
Led by CEO Skylar Talley, MedScout is a revenue acceleration platform designed to empower sales processes for medtech and life sciences companies. By combining medical claims intelligence with an intuitive user experience, it works with sales professionals and leaders to optimize their sales territories, prioritize best-fit opportunities, sell more efficiently, and build relationships with physicians. Additionally, MedScout provides commercial leadership with insights into their market opportunities, enabling them to align sales and marketing efforts for increased effectiveness.
FinSMEs
30/06/2023